UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash Flows From Operating Activities:
Net earnings	$ 16,441	$ 18,095
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	7,359	5,615
Reserves for credit losses, inventory obsolescence and sales returns	211	137
Share-based compensation expense	1,954	1,578
Excess tax benefit from exercise of stock options	(1,536)	(756)
Payments from lessees directly to lenders-operating leases	(4,062)	(2,391)
Gain on disposal of property, equipment and operating lease equipment	(1,001)	(560)
Gain on sale of notes receivable	(4,025)	(525)
Excess increase in cash value of life insurance	(67)	(75)
Other	109	(255)
Changes in:
Accounts receivable - trade	12,897	(11,958)
Accounts receivable - other	(4,087)	(7,593)
Notes receivable	(624)	1,028
Inventories	(5,043)	7,635
Investment in direct financing and sale-type leases-net	(7,569)	(795)
Deferred costs, other assets, and other assets	1,513	(506)
Accounts payable-equipment	1,700	(9,081)
Accounts payable-trade	(222)	(2,037)
Salaries and commissions payable, deferred revenue and accrued expenses and other liabilities	(8,387)	(4,949)
Net cash provided by (used in) operating activities	5,561	(7,393)
Cash Flows From Investing Activities:
Proceeds from sale of property, equipment and operating lease equipment	1,929	877
Purchases of property, equipment and operating lease equipment	(6,759)	(6,223)
Purchases of assets to be leased	(7,032)	0
Purchases of short-term investments	0	(1,232)
Maturities of short-term investments	982	6,658
Issuance of notes receivable	(45,847)	(17,237)
Repayments of notes receivable	16,031	9,387
Proceeds from sale of notes receivable	15,456	13,420
Premiums paid on life insurance	(93)	(43)
Net cash provided by (used in) investing activities	(25,333)	5,607
Cash Flows From Financing Activities:
Borrowings of non-recourse and recourse notes payable	12,779	14,605
Repayments of non-recourse and recourse notes payable	(1,135)	(500)
Repurchase of common stock	(5,901)	(1,557)
Dividends paid	(105)	0
Proceeds from issuance of capital stock through option exercise	559	178
Payments of contingent consideration	(1,027)	0
Excess tax benefit from share based compensation	1,536	756
Net borrowings (repayments) on floor plan facility	14,042	(1,545)
Net cash provided by financing activities	20,748	11,937
Effect of exchange rate changes on cash	0	6
Net Increase in Cash and Cash Equivalents	976	10,157
Cash and Cash Equivalents, Beginning of Period	52,720	33,778
Cash and Cash Equivalents, End of Period	53,696	43,935
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	15	1
Cash paid for income taxes	10,334	6,738
Schedule of Non-Cash Investing and Financing Activities:
Purchase of property and equipment included in accounts payable	71	62
Purchase of operating lease equipment included in accounts payable	241	175
Purchase of assets financed as notes receivables included in accounts payable	10,664	0
Proceeds from sales of operating lease equipment included in accounts receivable	12	143
Repayments of non-recourse and recourse notes payable	9,715	7,374
Vesting of share-based compensation	7,769	3,558
Origination and concurrent sale of notes receivable	$ 80,769	$ 0